Savient

Savient Names Lilly’s John Johnson Chief Executive
Bloomberg
Tue, 01/25/11 - 10:46 am
Savient
Eli Lilly
John Johnson
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
biotech
Cadence Pharmaceuticals
Cell Therapeutics
Enzon
Geron
Exelixis
Seattle Genetics
Savient
Vivus
Theravance
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:25 pm
Watson Pharmaceuticals
Theratechnologies
Shire
Savient
Sanofi
Roche
Orphan Europe
Novo Nordisk
Novartis
Merz
JNJ
HRA Pharma
Genzyme
Forest Labs
FDA
Eisai
Dainippon Sumitomo
Chemiche Fabrik Kresussler
Boehringer Ingelheim
Bayer
Auxilium
Amgen
Allergan
Acorda Therapeutics
Savient Reports Batch Failures With New Gout Medicine
Bloomberg
Fri, 01/7/11 - 10:34 am
Savient
gout
Krystexxa
2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
M&A
Pfizer
Merck
Genzyme
Sanofi
JNJ
Crucell
ONYX Pharmaceuticals
Bayer
Momenta
Novartis
GSK
Human Genome Sciences
Vertex Pharmaceuticals
MannKind
Vivus
Savient
Savient Pharma starts search for new CEO
Yahoo/AP
Wed, 12/29/10 - 10:51 am
Pharma CEOs
Savient
Is Savient the Perfect Stock?
Motley Fool
Tue, 11/9/10 - 01:17 pm
Savient
Savient: Risky but Promising Small Cap
Seeking Alpha
Sun, 10/31/10 - 10:58 am
Savient
gout
Oxandrin
Krystexxa
NJ's Savient plans to handle launch of new gout drug on its own
Newark Star-Ledger, NJ
Thu, 10/28/10 - 08:11 am
Savient
gout
Krystexxa
Look Beyond the Botched Buyout Process for Savient's Value
Seeking Alpha
Wed, 10/27/10 - 11:54 am
Savient
Should Investors Take A Chance On Savient?
Investopedia
Tue, 10/26/10 - 11:50 am
Savient
Krystexxa
Bristol-Myers Squibb
Forest Labs
Merck
Novartis
PDI Pharma
Pfizer
Savient Pharma: No Sale
TheStreet.com
Mon, 10/25/10 - 12:31 pm
M&A
Savient
4 M&A Targets With Notable Open Interest
Seeking Alpha
Sun, 10/24/10 - 01:35 pm
Genzyme
Savient
Seattle Genetics
Savient Investors Expect a Sale
TheStreet.com
Wed, 09/15/10 - 08:06 am
Savient
M&A
gout
FDA
Krystexxa
JNJ
Pfizer
Amgen
Novartis
Bristol-Myers Squibb
Savient Pharmaceuticals' Krystexxa Approved for Gout
Bloomberg
Wed, 09/15/10 - 07:35 am
Savient
gout
Krystexxa
FDA
Small Cap Biotech Stocks: 7 Picks, 1 Big Concern
Seeking Alpha
Sun, 09/12/10 - 11:20 am
Chelsea Therapeutics
Clinical Data
Savient
DUSA pharmaceuticals
Neurologix
Lpath
Savient: Drug Approval or Another Delay?
TheStreet.com
Fri, 09/10/10 - 11:15 am
Savient
Krystexxa
gout
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb
A Reintroduction to Savient's Krystexxa
Seeking Alpha
Thu, 08/12/10 - 11:28 am
Savient
Krystexxa
gout
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai

Pages